Lipid Metabolism Practice Questions

Q: Acetyl CoA is necessary for which of the following processes?

Fatty acid synthesis. **Explanation:** **Acetyl CoA** is the central hub of metabolism, serving as the primary substrate for the Citric Acid Cycle (TCA) and a crucial building block for lipid synthesis. **Why Option B is Correct:** Fatty acid synthesis (Lipogenesis) occurs in the **cytosol**. Acetyl CoA, produced in the mitochondria, is transported to the cytosol in the form of **Citrate**. Once in the cytosol, it is converted back to Acetyl CoA and then to **Malonyl CoA** by the enzyme *Acetyl CoA Carboxylase (ACC)*—the rate-limiting step of fatty acid synthesis. Thus, Acetyl CoA is the direct precursor for the long-chain fatty acid palmitate. **Why Other Options are Incorrect:** * **Option A (Amino acid synthesis):** While some carbon skeletons from the TCA cycle (like alpha-ketoglutarate or oxaloacetate) are used to synthesize non-essential amino acids, Acetyl CoA itself is not a direct precursor for amino acid synthesis. * **Option C (Glucose storage):** Glucose is stored as **Glycogen**. The precursor for glycogen synthesis is UDP-glucose, derived from Glucose-6-Phosphate. Acetyl CoA cannot be converted into glucose in humans (as we lack the glyoxylate shunt), meaning it cannot contribute to glucose storage. **NEET-PG High-Yield Pearls:** 1. **The "Citrate Shuttle":** Acetyl CoA cannot cross the inner mitochondrial membrane directly; it must combine with oxaloacetate to form **Citrate** to enter the cytosol for lipogenesis. 2. **Ketogenesis:** Acetyl CoA is also the precursor for ketone bodies (Acetoacetate, 3-hydroxybutyrate) during prolonged fasting. 3. **Irreversible Step:** The conversion of Pyruvate to Acetyl CoA by *Pyruvate Dehydrogenase (PDH)* is irreversible, explaining why fats cannot be converted back into glucose.

Q: Mitochondria is involved in all of the following functions, except:

Fatty acid biosynthesis. **Explanation:** The correct answer is **D. Fatty acid biosynthesis**. In biochemistry, the "compartmentalization" of metabolic pathways is a high-yield concept for NEET-PG. 1. **Why Fatty Acid Biosynthesis is the correct answer:** Fatty acid synthesis (Lipogenesis) occurs primarily in the **cytosol**. The process requires NADPH and Acetyl-CoA. While Acetyl-CoA is produced in the mitochondria, it must be transported to the cytosol via the "Citrate Shuttle" because the mitochondrial membrane is impermeable to it. In contrast, **Fatty acid oxidation (Beta-oxidation)** occurs within the mitochondria. 2. **Analysis of Incorrect Options:** * **A. ATP Production:** Known as the "powerhouse of the cell," mitochondria are the primary site for oxidative phosphorylation and the Electron Transport Chain (ETC), which generates the majority of cellular ATP. * **B. Apoptosis:** Mitochondria play a central role in the intrinsic pathway of apoptosis. The release of **Cytochrome c** from the mitochondrial intermembrane space into the cytosol activates caspases, leading to programmed cell death. * **C. Tricarboxylic acid (TCA) cycle:** All enzymes of the Krebs cycle (except succinate dehydrogenase, which is on the inner membrane) are located in the mitochondrial matrix. **High-Yield Clinical Pearls for NEET-PG:** * **Dual-site pathways:** Heme synthesis, Urea cycle, and Gluconeogenesis occur in **both** the mitochondria and cytosol (Mnemonic: **HUG**). * **Mitochondrial DNA:** It is circular, double-stranded, and inherited exclusively from the **mother**. * **Marker Enzyme:** **Succinate dehydrogenase** is the marker enzyme for the inner mitochondrial membrane and is also part of Complex II of the ETC.

Q: Acetyl-CoA generated from the metabolism of fatty acids can be converted into all of the following, except:

Glucose. **Explanation:** The conversion of Acetyl-CoA to glucose is impossible in humans because the **Pyruvate Dehydrogenase (PDH) complex reaction is irreversible**. 1. **Why Glucose is the correct answer:** In the metabolic pathway, Pyruvate is converted to Acetyl-CoA by the PDH complex. However, there is no enzyme in human tissues that can convert Acetyl-CoA back into Pyruvate or Oxaloacetate (net gain). While Acetyl-CoA enters the TCA cycle by condensing with Oxaloacetate, two carbons are lost as $CO_2$ during the cycle. Consequently, there is **no net synthesis of glucose** from Acetyl-CoA. This is why fatty acids (which break down into Acetyl-CoA) cannot be used for gluconeogenesis. 2. **Analysis of Incorrect Options:** * **Fatty Acids:** Acetyl-CoA is the primary substrate for fatty acid synthesis (Lipogenesis) via its conversion to Malonyl-CoA in the cytoplasm. * **Cholesterol:** Acetyl-CoA is the precursor for the entire steroid synthesis pathway. Two molecules of Acetyl-CoA form Acetoacetyl-CoA, eventually leading to HMG-CoA and then Mevalonate (the rate-limiting step of cholesterol synthesis). * **Ketone Bodies:** During starvation or uncontrolled diabetes, excess Acetyl-CoA from $\beta$-oxidation is diverted to Ketogenesis in the liver mitochondria to form Acetoacetate and $\beta$-hydroxybutyrate. **High-Yield Clinical Pearls for NEET-PG:** * **Odd-chain fatty acids** are the exception: Their metabolism yields **Propionyl-CoA**, which enters the TCA cycle as Succinyl-CoA and *can* be converted to glucose. * **Leucine and Lysine** are purely ketogenic amino acids because they are metabolized directly to Acetyl-CoA or Acetoacetate. * The **PDH complex** requires five cofactors: Thiamine ($B_1$), Riboflavin ($B_2$), Niacin ($B_3$), Pantothenic acid ($B_5$), and Lipoic acid.

Q: What is the mechanism for the transport of fatty acids across the mitochondrial membrane?

Facilitated transport. **Explanation:** The transport of long-chain fatty acids (LCFA) into the mitochondria is the rate-limiting step of **$\beta$-oxidation**. While short and medium-chain fatty acids can cross the mitochondrial membranes directly, LCFAs require a specialized shuttle system known as the **Carnitine Shuttle**. **Why Facilitated Transport is Correct:** The Carnitine Shuttle utilizes specific carrier proteins to move fatty acyl-CoA molecules across the inner mitochondrial membrane. This process involves **Carnitine Palmitoyltransferase I (CPT-I)** on the outer membrane and **CPT-II** on the inner membrane, along with a **Carnitine-acylcarnitine translocase**. Because this movement depends on specific membrane-bound transporters to move molecules across a biological membrane, it is classified as **facilitated transport**. **Analysis of Incorrect Options:** * **Active Transport:** This requires direct ATP hydrolysis to move solutes against a concentration gradient. The carnitine shuttle is a facilitated exchange mechanism, not a primary active pump. * **Diffusion:** LCFAs are too large and polar (when activated to Acyl-CoA) to freely diffuse through the impermeable inner mitochondrial membrane. * **Lipases:** These are enzymes (like Hormone-Sensitive Lipase) that hydrolyze triglycerides into free fatty acids and glycerol; they are not transport mechanisms. **High-Yield Clinical Pearls for NEET-PG:** * **Inhibitor:** **Malonyl-CoA** (the first intermediate of fatty acid synthesis) potently inhibits **CPT-I**, preventing a futile cycle where synthesis and oxidation occur simultaneously. * **Carnitine Deficiency:** Presents with non-ketotic hypoglycemia, muscle weakness, and cardiomyopathy during fasting. * **Location:** CPT-I is located in the outer mitochondrial membrane, while CPT-II is in the inner mitochondrial membrane.

Q: How do long-chain fatty acids enter the mitochondria?

By combining with carnitine. **Explanation:** The entry of long-chain fatty acids (LCFAs) into the mitochondria is the rate-limiting step of **beta-oxidation**. While short-chain and medium-chain fatty acids can diffuse freely, LCFAs cannot cross the impermeable inner mitochondrial membrane (IMM) on their own. **Why Option C is correct:** To cross the IMM, LCFAs must undergo the **Carnitine Shuttle**. First, they are activated to Fatty Acyl-CoA in the cytosol. The enzyme **Carnitine Palmitoyltransferase-I (CPT-I)** then replaces the CoA group with **carnitine**, forming Acyl-carnitine. This complex is transported across the IMM by a translocase. Once inside the matrix, **CPT-II** converts it back into Fatty Acyl-CoA and free carnitine. **Why other options are incorrect:** * **Options A & B:** The outer mitochondrial membrane contains porins (VDAC) that allow many molecules to pass, but the **inner membrane** is highly selective and lacks pores for fatty acids. Transport requires specific protein carriers. * **Option D:** **Ornithine** is an amino acid involved in the **Urea Cycle**, not lipid metabolism. It helps transport nitrogenous waste, not fatty acids. **High-Yield Clinical Pearls for NEET-PG:** * **Inhibitor:** **Malonyl-CoA** (the first intermediate of fatty acid synthesis) potently inhibits CPT-I. This prevents a "futile cycle" by ensuring synthesis and breakdown do not occur simultaneously. * **Systemic Carnitine Deficiency:** Presents with non-ketotic hypoglycemia, muscle weakness, and liver dysfunction because the body cannot utilize LCFAs for energy during fasting. * **Location:** CPT-I is located on the outer mitochondrial membrane; CPT-II is on the inner mitochondrial membrane.

Q: Which apolipoprotein is associated with Alzheimer's disease?

APOE4. **Explanation:** The correct answer is **APOE4**. Apolipoprotein E (ApoE) is a critical glycoprotein involved in the transport of lipids and cholesterol within the central nervous system. In humans, the APOE gene exists in three common alleles: ε2, ε3, and ε4. **Why APOE4 is correct:** The **APOE-ε4** allele is the strongest genetic risk factor for late-onset **Alzheimer’s Disease (AD)**. Mechanistically, ApoE4 is less efficient than other isoforms at clearing amyloid-beta (Aβ) peptides from the brain. This leads to increased Aβ aggregation and the formation of senile plaques, a hallmark of AD pathology. Carrying one copy of ε4 increases risk 3-fold, while two copies increase risk up to 12-fold. **Analysis of Incorrect Options:** * **APOE1:** This is not a common functional isoform in the human population and is not clinically relevant to Alzheimer’s risk. * **APOE2:** This isoform is actually considered **protective** against Alzheimer’s disease. However, it is associated with an increased risk of Type III Hyperlipoproteinemia (Dysbetalipoproteinemia). * **APOE3:** This is the most common (wild-type) isoform in the general population. It is considered "neutral" regarding Alzheimer’s risk. **High-Yield Clinical Pearls for NEET-PG:** * **ApoE Function:** It serves as a ligand for the LDL receptor, facilitating the uptake of chylomicron remnants and VLDL. * **Type III Hyperlipoproteinemia:** Associated with **ApoE2** homozygosity, resulting in elevated cholesterol and triglycerides due to poor clearance of IDL and remnants. * **Alzheimer’s Pathology:** Remember the "Amyloid Cascade Hypothesis"—ApoE4 promotes amyloid deposition and neurofibrillary tangles (Tau protein). * **Protective Factor:** APOE2 is the "good" allele for the brain; APOE4 is the "bad" allele.

Q: What is the primary enzymatic conversion performed by aromatase?

Androgen to estrogen. **Explanation:** **Aromatase** (also known as estrogen synthase or CYP19A1) is a member of the Cytochrome P450 superfamily. Its primary function is the conversion of **androgens to estrogens**. Specifically, it catalyzes the aromatization of the 'A' ring of the steroid nucleus, converting **androstenedione to estrone** and **testosterone to estradiol**. This process involves three successive hydroxylation steps requiring NADPH and molecular oxygen. **Analysis of Options:** * **Option B (Correct):** Aromatase is the rate-limiting enzyme that transforms C19 steroids (androgens) into C18 steroids (estrogens) by removing a methyl group and creating an aromatic ring. * **Option A:** This is the reverse process. Androgens are precursors to estrogens; there is no direct enzymatic pathway for aromatase to convert estrogens back into androgens. * **Option C:** Progesterone is a C21 steroid. It must first be converted to androgens (via 17α-hydroxylase and 17,20-lyase) before it can be converted to estrogens. * **Option D:** Androgens are downstream of progesterone in the steroidogenic pathway. **High-Yield Clinical Pearls for NEET-PG:** * **Localization:** Aromatase is highly expressed in the granulosa cells of the ovaries, adipose tissue, placenta, and the brain. * **Clinical Application:** **Aromatase Inhibitors** (e.g., Letrozole, Anastrozole, Exemestane) are first-line treatments for hormone-receptor-positive breast cancer in postmenopausal women. * **Aromatase Deficiency:** A rare condition leading to virilization of the female fetus and maternal virilization during pregnancy (due to the inability of the placenta to convert fetal androgens to estrogens). * **PCOS Connection:** In Polycystic Ovary Syndrome, there is often an altered LH/FSH ratio leading to relative aromatase inactivity in granulosa cells, contributing to hyperandrogenism.

Q: Which of the following is a primary ketone body that is formed from leucine, lysine, phenylalanine, and tyrosine?

Acetoacetate. **Explanation:** The synthesis of ketone bodies (ketogenesis) occurs primarily in the liver mitochondria. The process begins with the condensation of acetyl-CoA molecules to form **Acetoacetate**, which is the **first and primary ketone body** produced. **Why Acetoacetate is correct:** Ketogenic amino acids (Leucine and Lysine) and partially ketogenic amino acids (Phenylalanine and Tyrosine) are catabolized into either Acetyl-CoA or Acetoacetyl-CoA. These precursors enter the HMG-CoA pathway to form Acetoacetate. Because Acetoacetate is the parent molecule from which other ketone bodies are derived, it is considered the primary ketone body formed during the breakdown of these amino acids. **Why other options are incorrect:** * **B. Acetone:** This is a secondary ketone body formed by the non-enzymatic, spontaneous decarboxylation of acetoacetate. It is a waste product excreted via the lungs (causing "fruity breath"). * **C. Beta-hydroxybutyrate:** This is formed from the reduction of acetoacetate by the enzyme *β-hydroxybutyrate dehydrogenase*. While it is the predominant ketone body in the blood during ketosis, it is a secondary derivative, not the initial product. * **D. All of the above:** While all three are ketone bodies, only acetoacetate is the direct primary product formed from the ketogenic skeletons of the listed amino acids. **High-Yield NEET-PG Pearls:** * **Purely Ketogenic Amino Acids:** Leucine and Lysine (The "L"s). * **Rate-limiting enzyme of Ketogenesis:** HMG-CoA Synthase (Mitochondrial). * **Site of Utilization:** Ketone bodies are used by extrahepatic tissues (brain, heart, muscle) but **not by the liver**, because the liver lacks the enzyme **Thiophorase** (Succinyl-CoA:3-ketoacid CoA transferase). * **Detection:** The Rothera’s test detects Acetoacetate and Acetone, but **not** Beta-hydroxybutyrate.

Q: Which of the following is a glycosphingolipid?

Sphingomyelin. ### Explanation **Correct Answer: D. Sphingomyelin** **Concept:** Lipids are classified based on their backbone. **Sphingolipids** contain a complex amino alcohol called **sphingosine** instead of glycerol. Sphingomyelin is a unique phospholipid because it is the only sphingolipid that contains **phosphate** (as phosphorylcholine) but no sugar. While the question asks for a glycosphingolipid, in many standard medical classifications and exam contexts, Sphingomyelin is grouped under the broader category of sphingolipids due to its sphingosine backbone, distinguishing it from glycerol-based lipids. *Note: Strictly speaking, glycosphingolipids (like Cerebrosides and Gangliosides) contain carbohydrates. However, among the given options, Sphingomyelin is the only one belonging to the Sphingolipid family.* **Analysis of Incorrect Options:** * **A. Lecithin (Phosphatidylcholine):** This is a **glycerophospholipid**. It consists of a glycerol backbone, two fatty acids, and a choline group attached to a phosphate. * **B. Cardiolipin (Diphosphatidylglycerol):** Found exclusively in the inner mitochondrial membrane. It consists of two molecules of phosphatidic acid connected by a glycerol bridge. * **C. Plasmalogens:** These are specialized ether lipids where the fatty acid at the C1 position of glycerol is attached via an **ether linkage** (alkenyl group) rather than an ester bond. **High-Yield NEET-PG Pearls:** * **Niemann-Pick Disease:** Caused by a deficiency of **Sphingomyelinase**, leading to the accumulation of sphingomyelin in the liver, spleen, and brain (look for "Cherry Red Spot" on the macula). * **Surfactant:** Lecithin (Dipalmitoylphosphatidylcholine) is the major component of lung surfactant; an L/S ratio > 2 indicates fetal lung maturity. * **Barth Syndrome:** A rare X-linked disorder associated with abnormal cardiolipin metabolism, leading to cardiomyopathy.

Q: What is the best predictor for coronary artery disease?

LDL. **Explanation:** **Why LDL is the correct answer:** Low-Density Lipoprotein (LDL) is the primary carrier of cholesterol from the liver to peripheral tissues. It is considered the most significant independent risk factor and the **best predictor** for Coronary Artery Disease (CAD) because it is highly atherogenic. When LDL levels are elevated, they infiltrate the arterial intima, undergo oxidation, and are engulfed by macrophages to form "foam cells," the hallmark of atherosclerotic plaques. Clinical management of CAD primarily targets the lowering of LDL-C levels. **Analysis of Incorrect Options:** * **HDL (High-Density Lipoprotein):** Known as "good cholesterol," HDL facilitates reverse cholesterol transport (carrying cholesterol back to the liver). While low HDL is a risk factor, high levels are actually **cardioprotective**. * **VLDL (Very Low-Density Lipoprotein):** VLDL primarily transports endogenous triglycerides. While elevated VLDL contributes to metabolic syndrome, it is a precursor to LDL and not as direct a predictor of CAD as LDL itself. * **Chylomicrons:** These transport dietary (exogenous) triglycerides from the intestines. They are the least dense lipoproteins and are not directly implicated in the pathogenesis of atherosclerosis. **NEET-PG High-Yield Pearls:** * **Friedewald Formula:** LDL = Total Cholesterol – [HDL + (Triglycerides/5)]. (Note: This is invalid if TG >400 mg/dL). * **Apo-B100:** The characteristic apoprotein found in VLDL, IDL, and LDL. It is often cited as an even more precise marker of atherogenic particles than LDL-C. * **Lipoprotein (a):** An independent genetic risk factor for CAD; it is essentially an LDL particle with an attached Apo(a). * **Oxidized LDL:** The specific form of LDL that is most toxic to the endothelium and leads to plaque formation.

Question 1

Acetyl CoA is necessary for which of the following processes?

Accepted Answer

Fatty acid synthesis

Answer

Amino acid synthesis

Answer

Glucose storage

Answer

All of the above

Question 2

Mitochondria is involved in all of the following functions, except:

Accepted Answer

Fatty acid biosynthesis

Answer

ATP production

Answer

Apoptosis

Answer

Tricarboxylic acid cycle

Question 3

Acetyl-CoA generated from the metabolism of fatty acids can be converted into all of the following, except:

Accepted Answer

Glucose

Answer

Fatty Acids

Answer

Cholesterol

Answer

Ketone bodies

Question 4

What is the mechanism for the transport of fatty acids across the mitochondrial membrane?

Accepted Answer

Facilitated transport

Answer

Active transport

Answer

Diffusion

Answer

Lipases

Question 5

How do long-chain fatty acids enter the mitochondria?

Accepted Answer

By combining with carnitine

Answer

Through pores in the inner mitochondrial membrane

Answer

Through pores in the outer mitochondrial membrane

Answer

By combining with ornithine

Question 6

Which apolipoprotein is associated with Alzheimer's disease?

Accepted Answer

APOE4

Answer

APOE1

Answer

APOE2

Answer

APOE3

Question 7

What is the primary enzymatic conversion performed by aromatase?

Accepted Answer

Androgen to estrogen

Answer

Estrogen to androgen

Answer

Progesterone to estrogen

Answer

Androgen to progesterone

Question 8

Which of the following is a primary ketone body that is formed from leucine, lysine, phenylalanine, and tyrosine?

Accepted Answer

Acetoacetate

Answer

Acetone

Answer

Beta-hydroxybutyrate

Answer

All of the above

Question 9

Which of the following is a glycosphingolipid?

Accepted Answer

Sphingomyelin

Answer

Lecithin

Answer

Cardiolipin

Answer

Plasmalogens

Question 10

What is the best predictor for coronary artery disease?

Accepted Answer

LDL

Answer

HDL

Answer

VLDL

Answer

Chylomicron

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?